Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-05-01T06:27:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-24T01:46:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new collaborators, a revision update, and the specific mention of Acute Myeloid Leukemia in relapse. Notably, the previous detailed study rationale and objectives have been removed.
    Difference
    46%
    Check dated 2025-04-16T20:41:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T15:59:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:24:39.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T17:21:20.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.